Jump to navigation
Jump to main content
Chord Capital manages Sagentia Group's venture activities and is an FSA-regulated fund manager providing venture and investee companies access to world-class business and corporate finance skills
Jump to header
Critical care patients are set to benefit from chip-based sensing technologies that will allow healthcare professionals to take minimally invasive measurements of therapeutic drugs and blood chemistry
Find out more
CMR’s patented electrochemical flow-through fuel cell has attracted considerable interest in the market place. Commercial discussions with leading consumer electronics OEMs are ongoing and the core patent has been granted in China
Find out more
TurfTrax provides data to the media and consumer betting markets on horse racing. In conjunction with Sagentia it has developed and introduced the TurfTrax Tracking System which can capture a race as data and then broadcast the data to clients in real time
Find out more
Chord Capital has managed investments in more than 30 companies and co-invested with many separate venture capital firms. Find out more about approach and our unique investee companies
Find out more
Creating and exploiting intellectual property (IP) for both our clients and ourselves is key to Sagentia Group's business and is managed through Chord Capital. Find out more about how we develop innovative technologies in the widest range of industries and manage the exploitation of the associated IP
Find out more
